It is a chronic inflammatory skin condition that most often affects vulval and perianal skin. It may cause itching, soreness, fragility, fissures, white skin change and scarring, but symptoms and appearance vary. It is not an infection and cannot be passed through touch or sexual activity.

No. There is no permanent cure for LS. Nu-V is presented as a possible supportive option for selected women, not a cure or a way to end surveillance.

No. Potent prescription steroid ointment is established first-line care. Laser evidence is limited and mixed, so the procedure should not displace appropriate medical treatment.

It should not be presented as a replacement. Continue prescribed treatment unless the clinician responsible for your LS changes the plan.

A selected adult with a clear diagnosis, controlled disease, no suspicious lesion and a specific treatment goal may be considered after consultation. Suitability cannot be decided from symptoms alone.

LS usually affects external vulval or perianal skin, not the vaginal canal. External treatment is therefore the relevant LS discussion. Internal treatment is used only for a separately assessed vaginal indication when appropriate.

Yes. The clinician must be satisfied about the diagnosis and current condition of the skin. Diagnostic uncertainty should lead to further assessment rather than procedure-first treatment.

Not everyone needs one. Biopsy may be advised where the diagnosis is uncertain, treatment response is unusual or there is an open sore, thickened area or suspicious change. WHC will explain whether referral is needed.

Seek review for a new lump, persistent ulcer, thickened or crusted area, unexplained bleeding, rapidly changing appearance or a sore area that does not respond to prescribed treatment.

There is a small but important risk of vulval skin cancer in affected areas. Good disease control, lifelong self-examination and prompt review of suspicious change matter. Laser does not remove this risk or replace surveillance.

It delivers controlled energy in microscopic treatment zones. A tissue-remodelling response is intended, but that mechanism does not prove that laser controls LS inflammation, prevents scarring or reduces cancer risk.

Studies report mixed findings. Some describe symptom improvement, while sham-controlled trials and systematic reviews do not establish laser as effective monotherapy. High-quality long-term evidence remains limited.

WHC offers single-session and course-of-three pricing, but the correct plan varies. A course should be recommended only after assessment and reviewed as treatment progresses.

Both options are available, with different fees. The appropriate clinician is confirmed after the treatment area, complexity and proposed plan have been reviewed.

Comfort varies with skin condition, treatment area and settings. Warmth, stinging or tenderness may occur. Preparation and comfort measures are discussed before treatment; absence of discomfort is not promised.

Many women can return to ordinary non-strenuous activity relatively soon, but fragile LS skin may need longer. Temporary tenderness, redness, swelling, spotting, discharge or irritation can occur.

Follow the personalised aftercare advice for the area treated. Restrictions vary, and intercourse or friction should not resume while the tissue remains sore, swollen, bleeding or incompletely healed.

Possible risks include pain, irritation, swelling, bleeding, infection, pigment change, burns, delayed healing, scarring, altered sensation, flare or worsening symptoms. Rare or device-specific risks are explained during consent.

There is no guaranteed timetable or outcome. Any change should be assessed against the agreed goal, symptoms, examination findings, established-treatment use and natural fluctuation of LS.

Permanent results cannot be promised. LS remains a chronic condition. Annual top-up pricing exists, but further laser is offered only after reassessment—not automatically.

Alternatives depend on the main problem and may include optimising prescribed LS treatment, specialist vulval review, barrier care, treatment for coexisting GSM or infection, pelvic-floor physiotherapy, pain support, dilators or surgery for selected functional scarring.

Laser is generally postponed where pregnancy, active inflammation, ulceration, infection or impaired healing makes treatment unsuitable. Individual contraindications are checked during assessment.

Consultation is £150. A single session is £599 nurse-led or £799 doctor-led. A course of three is £1,200 nurse-led or £1,800 doctor-led. Annual top-up pricing is £400 nurse-led or £600 doctor-led.

Pictures may help you recognise that a vulval change deserves review, but they cannot confirm LS. Lighting, skin tone and overlapping conditions can make self-diagnosis unreliable. Examination—and sometimes biopsy—is the safer route.

Gentle skin care, a suitable emollient or barrier product and avoiding irritants can support comfort. No diet, oil, probiotic, supplement or other natural remedy has been shown to cure LS or replace prescription steroid treatment. Check products with a clinician because natural ingredients can still irritate or cause allergy.

Both are inflammatory conditions, but they differ in typical appearance and distribution. LS usually affects pale, fragile external vulval or perianal skin; erosive lichen planus may look red or glazed and can involve the vagina or mouth. Overlap is possible, so diagnosis should be clinical rather than based on a checklist.

No. Laser and surgery have different roles. Functional scarring, adhesions, clitoral phimosis or significant narrowing may need specialist surgical assessment. Labiaplasty is not a treatment for active LS inflammation and should not be assumed from appearance alone.

Tell us about anticoagulants or antiplatelet medicines, bleeding disorders, diabetes, immune suppression, wound-healing problems, previous pelvic radiotherapy or surgery, pregnancy or recent childbirth, active infection and earlier reactions to laser. Do not stop prescribed medication unless the responsible prescriber tells you to.

This page discusses Nu-V as a private supportive treatment considered within medical LS care, not as a guaranteed cosmetic transformation. The consultation identifies the actual concern and whether a medical, functional, surgical or no-procedure route is most appropriate.

Clinic and practitioner availability can vary. Contact WHC with your preferred location and whether you are seeking a nurse-led or doctor-led route; the team can confirm the current consultation and treatment options.